ReviewGenetics2025
The 5' truncation of retrotransposon L1: a process of genome integrity.
Review in Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Diversity and genome engineering applications of R2 non-LTR retrotransposons.RNA (New York, N.Y.) · 2026Review
- DNA-bound avian R2 non-LTR retrotransposon protein recruits a second R2 protein for genome-protective second-strand nicking.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Human CCR4-NOT suppresses pervasive transcription and retrotransposable elements.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Long interspersed element 1 (LINE1/L1) is a family of non-LTR retrotransposons that is active in mammals and has expanded dramatically to become 17% of the human genome. L1 activity in humans was first discovered as spontaneous insertions resulting in Mendelian disease. In subsequent years, much has been learned about the 2 L1 encoded proteins (ORF1 and ORF2) and host factors involved in transposition. Research describing many aspects of integration has been captured in important review papers. However, we know of no review dedicated to what is perhaps one of the most unusual features of L1, the 5' truncation that removes most of its sequence in 95% of insertions. Many consider this to be a form of host defense. By removing large portions of L1 during integration, 5' truncation has limited L1-mediated expansion of the genome by approximately 5 Gb. In this review, we discuss size distribution of 5' truncations and how this varies depending on the age and subfamily of the element. Of particular value is the recent telomere to telomere assembly of ultra-long sequence reads that document 1 million copies of L1. Studies of L1 integration show that 5' truncation occurs in germ cells, somatic tissues, and cancer cells. In addition, nonhuman primates, rodents, insects, and yeast contain L1 family elements that exhibit 5' truncation. Experiments have identified host factors that restrict transposition activity and have led to compelling proposals for how 5' truncation occurs. The proposed mechanisms and their implications are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.